S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
Blue Chips And Billionaires Quietly Investing In "The New Oil" (Ad)
4 stocks benefitting from NVIDIA's explosive growth
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
Blue Chips And Billionaires Quietly Investing In "The New Oil" (Ad)
MILAN FASHION PHOTOS: Feben, Rave Review promote looks for women of all shapes, ages and sizes
Caribbean leaders meet with Haiti's prime minister. Foreign force deployment is on the agenda
Blue Chips And Billionaires Quietly Investing In "The New Oil" (Ad)
Stock market today: Global shares mostly decline, while Tokyo again finishes at a record high
Analysts boosted Snowflake stock, big firms are buying now
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
Blue Chips And Billionaires Quietly Investing In "The New Oil" (Ad)
4 stocks benefitting from NVIDIA's explosive growth
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
Blue Chips And Billionaires Quietly Investing In "The New Oil" (Ad)
MILAN FASHION PHOTOS: Feben, Rave Review promote looks for women of all shapes, ages and sizes
Caribbean leaders meet with Haiti's prime minister. Foreign force deployment is on the agenda
Blue Chips And Billionaires Quietly Investing In "The New Oil" (Ad)
Stock market today: Global shares mostly decline, while Tokyo again finishes at a record high
Analysts boosted Snowflake stock, big firms are buying now
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
Blue Chips And Billionaires Quietly Investing In "The New Oil" (Ad)
4 stocks benefitting from NVIDIA's explosive growth
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
Blue Chips And Billionaires Quietly Investing In "The New Oil" (Ad)
MILAN FASHION PHOTOS: Feben, Rave Review promote looks for women of all shapes, ages and sizes
Caribbean leaders meet with Haiti's prime minister. Foreign force deployment is on the agenda
Blue Chips And Billionaires Quietly Investing In "The New Oil" (Ad)
Stock market today: Global shares mostly decline, while Tokyo again finishes at a record high
Analysts boosted Snowflake stock, big firms are buying now
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
Blue Chips And Billionaires Quietly Investing In "The New Oil" (Ad)
4 stocks benefitting from NVIDIA's explosive growth
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
Blue Chips And Billionaires Quietly Investing In "The New Oil" (Ad)
MILAN FASHION PHOTOS: Feben, Rave Review promote looks for women of all shapes, ages and sizes
Caribbean leaders meet with Haiti's prime minister. Foreign force deployment is on the agenda
Blue Chips And Billionaires Quietly Investing In "The New Oil" (Ad)
Stock market today: Global shares mostly decline, while Tokyo again finishes at a record high
Analysts boosted Snowflake stock, big firms are buying now

ProMIS Neurosciences (PMN) Short Interest Ratio & Short Volume

$2.08
+0.13 (+6.67%)
(As of 02/23/2024 08:53 PM ET)

ProMIS Neurosciences Short Interest Data

Current Short Volume
27,500 shares
Previous Short Volume
20,000 shares
Change Vs. Previous Month
+37.50%
Dollar Volume Sold Short
$55,000.00
Short Interest Ratio / Days to Cover
0.6
Last Record Date
January 31, 2024
Outstanding Shares
18,890,000 shares
Float Size
6,740,000 shares
Short Percent of Float
0.41%
Today's Trading Volume
5,400 shares
Average Trading Volume
62,843 shares
Today's Volume Vs. Average
9%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling ProMIS Neurosciences ?

Sign up to receive the latest short interest report for ProMIS Neurosciences and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

PMN Short Interest Over Time

PMN Days to Cover Over Time

PMN Percentage of Float Shorted Over Time


ProMIS Neurosciences Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
1/31/202427,500 shares $55,000.00 No Change0.4%0.6 $2.00
6/15/2023200 shares $984.00 -33.3%N/A0.1 $4.92
5/31/2023300 shares $1,467.39 No ChangeN/A0.1 $4.89
5/15/2023300 shares $1,764.00 No ChangeN/A0.1 $5.88













PMN Short Interest - Frequently Asked Questions

What is ProMIS Neurosciences' current short interest?

Short interest is the volume of ProMIS Neurosciences shares that have been sold short but have not yet been covered or closed out. As of January 31st, traders have sold 27,500 shares of PMN short. 0.41% of ProMIS Neurosciences' shares are currently sold short. Learn More on ProMIS Neurosciences' current short interest.

What is a good short interest ratio for ProMIS Neurosciences?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PMN shares currently have a short interest ratio of 1.0. Learn More on ProMIS Neurosciences's short interest ratio.

What is a good short interest percentage for ProMIS Neurosciences?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.41% of ProMIS Neurosciences' floating shares are currently sold short.

Is ProMIS Neurosciences' short interest increasing or decreasing?

ProMIS Neurosciences saw a increase in short interest in January. As of January 31st, there was short interest totaling 27,500 shares, an increase of 37.5% from the previous total of 20,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is ProMIS Neurosciences' float size?

ProMIS Neurosciences currently has issued a total of 18,890,000 shares. Some of ProMIS Neurosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. ProMIS Neurosciences currently has a public float of 6,740,000 shares.

How does ProMIS Neurosciences' short interest compare to its competitors?

0.41% of ProMIS Neurosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to ProMIS Neurosciences: FSD Pharma Inc. (1.87%), Cara Therapeutics, Inc. (5.43%), YS Biopharma Co., Ltd. (0.43%), Marker Therapeutics, Inc. (2.74%), Daré Bioscience, Inc. (0.57%), Rockwell Medical, Inc. (2.16%), Gyre Therapeutics, Inc. (1.71%), NRx Pharmaceuticals, Inc. (5.06%), Cumberland Pharmaceuticals Inc. (0.37%), Regulus Therapeutics Inc. (0.67%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.48 billion), General Motors ($3.85 billion), Charter Communications, Inc. ($3.38 billion), Occidental Petroleum Co. ($3.00 billion), Super Micro Computer, Inc. ($2.66 billion), Tractor Supply ($2.37 billion), Coinbase Global, Inc. ($2.25 billion), Moderna, Inc. ($2.11 billion), Royal Caribbean Cruises Ltd. ($2.06 billion), and Floor & Decor Holdings, Inc. ($1.67 billion). View all of the most shorted stocks.

What does it mean to sell short ProMIS Neurosciences stock?

Short selling PMN is an investing strategy that aims to generate trading profit from ProMIS Neurosciences as its price is falling. PMN shares are trading up $0.13 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against ProMIS Neurosciences?

A short squeeze for ProMIS Neurosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PMN, which in turn drives the price of the stock up even further.

How often is ProMIS Neurosciences' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PMN, twice per month. The most recent reporting period available is January, 31 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:PMN) was last updated on 2/26/2024 by MarketBeat.com Staff